NASDAQ: BIOABioage Labs Inc Stock Ownership - Who owns Bioage Labs?
Insider buying vs selling
Have Bioage Labs Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul D. Rubin | Chief Medical Officer | 2026-02-02 | 7,433 | $18.75 | $139.37kSell |
| Paul D. Rubin | Chief Medical Officer | 2026-02-02 | 2,000 | $6.57 | $13.14kBuy |
| Paul D. Rubin | Chief Medical Officer | 2026-02-02 | 5,433 | $4.11 | $22.33kBuy |
| Dov A. Md Goldstein | Chief Financial Officer | 2026-02-01 | 3,541 | $4.38 | $15.51kBuy |
| Dov A. Md Goldstein | Chief Financial Officer | 2026-01-16 | 3,542 | $4.38 | $15.51kBuy |
| Dov A. Md Goldstein | Chief Financial Officer | 2026-01-13 | 1,923 | $21.08 | $40.54kSell |
| Kristen Fortney | Chief Executive Officer | 2026-01-13 | 233,107 | $18.12 | $4.22MSell |
| Dov A. Md Goldstein | Chief Financial Officer | 2026-01-13 | 27,000 | $8.39 | $226.53kBuy |
| Dov A. Md Goldstein | Chief Financial Officer | 2026-01-13 | 8,974 | $18.43 | $165.37kSell |
| Dov A. Md Goldstein | Chief Financial Officer | 2026-01-13 | 4,440 | $19.45 | $86.37kSell |
BIOA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BIOA insiders and whales buy or sell their stock.
BIOA Shareholders
What type of owners hold Bioage Labs Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vijay Satyanand Pande | 9.02% | 3,233,170 | $63.27M | Insider |
| James Healy | 6.43% | 2,304,901 | $45.11M | Insider |
| Sofinnova Investments Inc | 6.40% | 2,293,788 | $44.89M | Institution |
| Patrick G. Enright | 4.77% | 1,710,589 | $33.48M | Insider |
| Cormorant Asset Management LP | 4.54% | 1,629,529 | $31.89M | Insider |
| Blackrock Inc | 4.26% | 1,527,541 | $29.89M | Institution |
| Vanguard Group Inc | 3.95% | 1,414,770 | $27.69M | Institution |
| Kristen Fortney | 2.72% | 976,949 | $19.12M | Insider |
| Sands Capital Alternatives LLC | 2.19% | 786,353 | $15.39M | Institution |
| Pivotal Bioventure Partners Investment Advisor LLC | 1.82% | 653,374 | $12.79M | Institution |
BIOA vs Pharmaceutical Stocks
Bioage Labs Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.